These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 31695840)

  • 81. Inhibitors targeting CDK4/6, PARP and PI3K in breast cancer: a review.
    Nur Husna SM; Tan HT; Mohamud R; Dyhl-Polk A; Wong KK
    Ther Adv Med Oncol; 2018; 10():1758835918808509. PubMed ID: 30542378
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Ribociclib in Breast Cancer Brain Metastases: A Case Report.
    Radke I; von Wahlde MK; Schülke C; Tio J
    Breast Care (Basel); 2020 Oct; 15(5):543-547. PubMed ID: 33224000
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Prognostic characteristics in hormone receptor-positive advanced breast cancer and characterization of abemaciclib efficacy.
    Di Leo A; O'Shaughnessy J; Sledge GW; Martin M; Lin Y; Frenzel M; Hardebeck MC; Smith IC; Llombart-Cussac A; Goetz MP; Johnston S
    NPJ Breast Cancer; 2018; 4():41. PubMed ID: 30588487
    [TBL] [Abstract][Full Text] [Related]  

  • 84. CDK4/6 inhibitors in the treatment of patients with breast cancer: summary of a multidisciplinary round-table discussion.
    Preusser M; De Mattos-Arruda L; Thill M; Criscitiello C; Bartsch R; Ruhstaller T; de Azambuja E; Zielinski CC
    ESMO Open; 2018; 3(5):e000368. PubMed ID: 30167331
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Cdk4/6 inhibitors and overall survival: power of first-line trials in metastatic breast cancer.
    Tanguy ML; Cabel L; Berger F; Pierga JY; Savignoni A; Bidard FC
    NPJ Breast Cancer; 2018; 4():14. PubMed ID: 29951582
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Circulating Biomarkers of CDK4/6 Inhibitors Response in Hormone Receptor Positive and HER2 Negative Breast Cancer.
    Migliaccio I; Leo A; Galardi F; Guarducci C; Fusco GM; Benelli M; Di Leo A; Biganzoli L; Malorni L
    Cancers (Basel); 2021 May; 13(11):. PubMed ID: 34072070
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Targeted Therapies for Breast Cancer Brain Metastases.
    Cali Daylan AE; Leone JP
    Clin Breast Cancer; 2021 Aug; 21(4):263-270. PubMed ID: 33384227
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Exclusion of Patients With Brain Metastases in Published Phase III Clinical Trials for Advanced Breast Cancer.
    Sharma A; Searle K; Hasan S; Chan S; Pond G; Jerzak KJ
    Clin Breast Cancer; 2022 Oct; 22(7):629-633. PubMed ID: 35965204
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Anti-angiogenetic therapies for central nervous system metastases from non-small cell lung cancer.
    Buttigliero C; Bertaglia V; Novello S
    Transl Lung Cancer Res; 2016 Dec; 5(6):610-627. PubMed ID: 28149756
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Intracranial Response Rate in Patients with Breast Cancer Brain Metastases after Systemic Therapy.
    Niwinska A; Pogoda K; Jagiello-Gruszfeld A; Duchnowska R
    Cancers (Basel); 2022 Feb; 14(4):. PubMed ID: 35205723
    [TBL] [Abstract][Full Text] [Related]  

  • 91.
    Gao YY; Yang RQ; Lou KL; Dang YY; Dong YY; He YY; Huang WH; Chen M; Zhang GJ
    MedComm (2020); 2022 Sep; 3(3):e136. PubMed ID: 35711853
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Update Breast Cancer 2020 Part 2 - Advanced Breast Cancer: New Treatments and Implementation of Therapies with Companion Diagnostics.
    Lüftner D; Schneeweiss A; Hartkopf AD; Müller V; Wöckel A; Janni W; Ettl J; Belleville E; Schütz F; Thill M; Huober J; Fasching PA; Kolberg HC; Pöschke P; Welslau M; Overkamp F; Tesch H; Fehm TN; Lux MP
    Geburtshilfe Frauenheilkd; 2020 Apr; 80(4):391-398. PubMed ID: 32322108
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Updates on Molecular Targeted Therapies for Intraparenchymal CNS Metastases.
    Sharma A; Singer L; Kumthekar P
    Cancers (Basel); 2021 Dec; 14(1):. PubMed ID: 35008185
    [TBL] [Abstract][Full Text] [Related]  

  • 94. CDK4/6 inhibitors in advanced breast cancer, what is beyond?
    Mohammed AA; Rashied H; Elsayed FM
    Oncol Rev; 2019 Jul; 13(2):416. PubMed ID: 31452841
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Treatment of Breast Cancer Brain Metastases.
    Freedman RA; Anders CK
    Curr Breast Cancer Rep; 2012 Mar; 4(1):1-9. PubMed ID: 22754605
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Radiotherapeutic Strategies to Overcome Resistance of Breast Cancer Brain Metastases by Considering Immunogenic Aspects of Cancer Stem Cells.
    Hintelmann K; Petersen C; Borgmann K
    Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612206
    [TBL] [Abstract][Full Text] [Related]  

  • 97. IMPACT the Brain: A Team-Based Approach to Management of Metastatic Breast Cancer With CNS Metastases.
    Fleege NMG; Pierce-Gjeldum D; Swartz LK; Verbal K; Merajver S; Friese CR; Kiyota A; Heth J; Leung D; Smith SR; Gabel N; Kim MM; Morikawa A
    JCO Oncol Pract; 2023 Jan; 19(1):e67-e77. PubMed ID: 36223556
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Molecular determinants of lung cancer metastasis to the central nervous system.
    Whitsett TG; Inge LJ; Dhruv HD; Cheung PY; Weiss GJ; Bremner RM; Winkles JA; Tran NL
    Transl Lung Cancer Res; 2013 Aug; 2(4):273-83. PubMed ID: 25806243
    [TBL] [Abstract][Full Text] [Related]  

  • 99. A Protracted Course of COVID19 Infection in a Metastatic Breast Cancer Patient During CDK4/6 Inhibitor Therapy.
    Grinshpun A; Merlet I; Fruchtman H; Nachman D
    Front Oncol; 2020; 10():1085. PubMed ID: 32582559
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Systemic Therapy of Advanced/Metastatic Breast Cancer - Current Evidence and Future Concepts.
    Liedtke C; Kolberg HC
    Breast Care (Basel); 2016 Aug; 11(4):275-281. PubMed ID: 27721716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.